Groupama Asset Managment Legend Biotech Corp Transaction History
Groupama Asset Managment
- $7.37 Trillion
- Q2 2024
A detailed history of Groupama Asset Managment transactions in Legend Biotech Corp stock. As of the latest transaction made, Groupama Asset Managment holds 22,782 shares of LEGN stock, worth $993,523. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22,782
Previous 21,422
6.35%
Holding current value
$993,523
Previous $1.2 Billion
16.02%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
202Shares Held
74.3MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$501 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$327 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$289 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$250 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$208 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.3B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...